The suppressor of cytokine signaling 2 (SOCS2) was screened out by RNA-seq and bioinformatics analyses as a potential prognosis predictor of HCC radiotherapy and then was determined to promote radiosensitivity in HCC both in vivo or in vitro.
[Cell Death & Differentiation]